Clinical Trial Update: Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Vitreous Hemorrhage [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating adjuvant intravitreal bevacizumab during pars plana vitrectomy for vitreous hemorrhage due to proliferative diabetic retinopat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Proliferative Diabetic Retinopathy

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: University of Sao Paulo | Conditions: Vitreous Hemorrhage Secondary to PDR | Phase 2 | Status: UNKNOWN